Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer.
1/5 보강
Anaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy characterized by advanced disease at diagnosis and a poor prognosis.
APA
Sekihara K, Himuro H, et al. (2024). Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer.. Biomedicines, 12(6). https://doi.org/10.3390/biomedicines12061286
MLA
Sekihara K, et al.. "Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer.." Biomedicines, vol. 12, no. 6, 2024.
PMID
38927493 ↗
Abstract 한글 요약
Anaplastic thyroid cancer (ATC) is a rare but highly aggressive malignancy characterized by advanced disease at diagnosis and a poor prognosis. Despite multimodal therapeutic approaches that include surgery, radiotherapy, and chemotherapy, an optimal treatment strategy remains elusive. Current developments in targeted therapies and immunotherapy offer promising avenues for improved outcomes, particularly for -mutant patients. However, challenges remain regarding overcoming drug resistance and developing effective treatments for -wild-type tumors. This comprehensive review examines the clinical and biological features of ATC, outlines the current standards of care, and discusses recent developments with a focus on the evolving role of radiotherapy. Moreover, it emphasizes the necessity of a multidisciplinary approach and highlights the urgent need for further research to better understand ATC pathogenesis and identify new therapeutic targets. Collaborative efforts, including large-scale clinical trials, are essential for translating these findings into improved patient outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
- Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions.
- A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF Mutant Metastatic Colorectal Cancer: The NAUTICAL Study.
- Exploring Gallium(III) Complexes as Emerging Therapeutic Candidates for Breast Cancer.
- Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study.
- Chemical modification of STL427944 toward morpholine-based 1,3,5-triazines as anticancer agents targeting FOXM1: green synthesis, biological evaluation and ADME-Tox profiling in a colorectal cancer model.